Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

IMPORTANCE: In cancer clinical trials, symptomatic adverse events (AEs), such as nausea, are reported by investigators rather than by patients. There is increasing interest to collect symptomatic AE data via patient-reported outcome (PRO) questionnaires, but it is unclear whether it is feasible to i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Basch, Ethan, Dueck, Amylou C., Rogak, Lauren J., Minasian, Lori M., Kelly, William Kevin, O’Mara, Ann M., Denicoff, Andrea M., Seisler, Drew, Atherton, Pamela J., Paskett, Electra, Carey, Lisa, Dickler, Maura, Heist, Rebecca S., Himelstein, Andrew, Rugo, Hope S., Sikov, William M., Socinski, Mark A., Venook, Alan P., Weckstein, Douglas J., Lake, Diana E., Biggs, David D., Freedman, Rachel A., Kuzma, Charles, Kirshner, Jeffrey J., Schrag, Deborah
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553624/
https://ncbi.nlm.nih.gov/pubmed/28208174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.6749
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados